WallStSmart
CRON

Cronos Group Inc

NASDAQ: CRON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.58
-2.64% today

Updated 2026-04-29

Market cap
$1.02B
P/E ratio
P/S ratio
6.93x
EPS (TTM)
$-0.02
Dividend yield
52W range
$2 – $3
Volume
1.5M

Cronos Group Inc (CRON) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
+201.3%
Most recent quarter
EPS YoY growth
-103.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+1.2%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$-0.00-123.5%$2.63$2.62-0.4%
2025-11-06$0.07+250.0%$2.45$2.48+1.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.02$-0.00-123.5%$91.31M+201.3%
2025-09-30$0.02$0.07+250.0%$36.34M+6.1%
2025-06-30$0.02$-0.10-600.0%$33.45M+20.5%
2025-03-31$-0.00$0.03+894.3%$32.26M+27.6%
2024-12-31$-0.01$0.16+1806.5%$30.30M+26.7%
2024-09-30$-0.01$0.02+316.0%$34.26M+38.1%
2024-06-30$-0.01$-0.02-100.0%$27.76M+46.0%
2024-03-31$-0.01$-0.01+0.0%$25.29M+29.7%
2023-12-31$-0.01$-0.05-400.0%$23.91M
2023-09-30$-0.02$-0.00+78.5%$24.81M
2023-06-30$-0.03$-0.01+66.7%$19.02M
2023-03-31$-0.05$-0.05+0.0%$19.50M

Frequently asked questions

Has Cronos Group Inc beaten earnings estimates?
Cronos Group Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports.
How does CRON stock react to earnings?
CRON stock has moved an average of +0.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Cronos Group Inc's revenue growth rate?
Cronos Group Inc reported year-over-year revenue growth of +201.3% in its most recent quarter, with EPS growing -103.0% year-over-year.